186 terminated. 186 Phase 2, 41 Phase 1, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 186 | Terminated 186 |
| Phase 1 | 41 | Terminated 41 |
| Phase 3 | 4 | Terminated 4 |
Follow Radiotherapy: new trials by email Literature Review of Radiotherapy trials Research Report on Radiotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - CIC-Rearranged Sarcoma, Metastatic Ewing Sarcoma | Phase 2 / Phase 3 | Terminated | Children's Oncology Group | 2 | 2025-11-10 | 2026-10-05 |
| First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC Radiotherapy, HAIC (GEMOX), Chemotherapy - Intrahepatic Cholangiocarcinoma | Phase 2 | Terminated | Shandong Cancer Hospital and Institute | 1 | 2024-04-01 | 2025-06-25 |
| Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer Cisplatin, Carboplatin, Etoposide - Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer | Phase 2 | Terminated | Vanderbilt-Ingram Cancer Center | 1 | 2024-02-14 | 2025-06-05 |
| Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies. Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG) - Hematologic Malignancy, Myeloid Malignancy | Phase 2 | Terminated | St. Jude Children's Research Hospital | 3 | 2023-03-14 | 2025-10-02 |
| A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors GEN1042, Pembrolizumab, Radiotherapy - Non-CNS Tumor | Phase 1 / Phase 2 | Terminated | Genmab | 13 | 2023-03-08 | 2026-08-12 |
| Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma Sonidegib, Cisplatin, Lomustine - Medulloblastoma | Phase 2 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 20 | 2022-11-11 | 2025-10-23 |
| Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer Radiation Therapy - Prostate Cancer | Phase 2 | Terminated | Weill Medical College of Cornell University | 33 | 2022-02-11 | 2026-04-23 |
| Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site Atezolizumab, Radiation Therapy, Therapeutic Conventional Surgery - Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Terminated | University of California, Davis | 1 | 2021-12-07 | 2026-06-05 |
| Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC durvalumab plus platinum-based chemotherapy (cisplatin or carboplatin plus vinorelbine or pemetrexed), Durvalumab plus radiotherapy, durvalumab - Non-small Cell Lung Cancer Stage III | Phase 2 | Terminated | Mario Negri Institute for Pharmacological Research | 10 | 2021-09-24 | 2025-12-16 |
| Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies Atezolizumab, Avelumab, Durvalumab - Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma | Phase 1 / Phase 2 | Terminated | M.D. Anderson Cancer Center | 19 | 2021-04-14 | 2026-04-30 |
| Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer Abemaciclib 150 MG by mouth twice daily, Androgen deprivation therapy (ADT), Radiation Therapy - Prostate Cancer | Phase 2 | Terminated | University of Alabama at Birmingham | 9 | 2021-02-25 | 2025-03-19 |
| Perioperative Therapy for Hepatocellular Carcinoma Sintilimab Injection, TACE, Radiotherapy - Hepatocellular Carcinoma | Phase 2 | Terminated | Zhejiang University | 10 | 2020-12-26 | 2022-01-11 |
| A Study of Tislelizumab Combined With Radiotherapy as the Second-line Treatment of Advanced Biliary Malignant Tumors Radiotherapy - Cholangiocarcinoma | Phase 2 | Terminated | The First Affiliated Hospital with Nanjing Medical University | 20 | 2020-10-01 | 2025-03-21 |
| Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise Radiation therapy - COVID-19 | Phase 2 | Terminated | Ohio State University | 2 | 2020-07-23 | 2026-08-19 |
| Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer Antiandrogen Therapy, Abiraterone Acetate, Prednisone - Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone | Phase 2 | Terminated | University of Washington | 10 | 2020-06-29 | 2023-10-26 |
| Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities Cabozantinib S-malate, Radiation Therapy - Sarcoma of the Extremity, Stage I Soft Tissue Sarcoma of the Trunk and Extremities | Phase 1 / Phase 2 | Terminated | University of Washington | 6 | 2020-06-01 | 2025-07-17 |
| A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy Hydroxychloroquine, Placebo, Radiation therapy - COVID-19, Cancer | Phase 2 | Terminated | Memorial Sloan Kettering Cancer Center | 4 | 2020-05-07 | 2021-10-27 |
| Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 Low Dose Radiation Therapy - Pneumonia, Coronavirus Infection in 2019 (COVID-19) | Phase 1 / Phase 2 | Terminated | Emory University | 47 | 2020-04-24 | 2022-03-29 |
| IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma hu14.18-IL2, Radiation Therapy, Nivolumab - Melanoma | Phase 1 / Phase 2 | Terminated | University of Wisconsin, Madison | 8 | 2020-01-30 | 2026-06-03 |
| Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma Cetuximab, Cisplatin, Quality-of-Life Assessment - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 | Terminated | Jonsson Comprehensive Cancer Center | 1 | 2020-01-14 | 2023-06-01 |
Showing 20 of 186. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (25) · Lung Neoplasms (17) · Breast Neoplasms (12) · Head and Neck Neoplasms (11) · Adenocarcinoma Of Esophagus (10) · Esophageal Neoplasms (10) · Squamous Cell Carcinoma of Head and Neck (10) · Leukemia (9) · Lymphoma (9) · Lymphoma, Non-Hodgkin (9) · Rectal Neoplasms (9) · Glioblastoma (8) · Pancreatic Neoplasms (8) · Prostatic Neoplasms (7) · Brain Neoplasms (6)
European Organisation for Research and Treatment of Cancer - EORTC (8) · M.D. Anderson Cancer Center (7) · Masonic Cancer Center, University of Minnesota (7) · SWOG Cancer Research Network (7) · University of Washington (7) · Roswell Park Cancer Institute (5) · Weill Medical College of Cornell University (5) · Alliance for Clinical Trials in Oncology (4) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (4) · Stanford University (4) · Case Comprehensive Cancer Center (3) · City of Hope Medical Center (3) · Genmab (3) · NYU Langone Health (3) · National Cancer Institute (NCI) (3)
United States (137) · France (18) · Belgium (9) · Italy (9) · Netherlands (9) · United Kingdom (9) · Spain (7) · China (6) · Germany (6) · Canada (4) · Australia (3) · Poland (3) · Switzerland (3) · Taiwan (2) · Austria (1)
Aude Chapuis (2) · Catherine M. Verfaillie, MD (2) · Dolores Grosso, DNP, CRNP (2) · Jing Zeng (2) · Nasser Hanna, M.D. (2) · Neal Flomenberg, MD (2) · Paul Walker, MD (2) · Stuart A. Grossman, MD (2) · Vicki Keedy, MD (2) · Abdul-Rahman Jazieh, MD, MPH (1) · Abraham Leung, MD (1) · Adriaan Moelker, MD PhD (1) · Adriana Rossi, M.D. (1) · Adrienne C Scheck, PhD (1)
PMID 15246197, PMID 17938330, PMID 18568488, PMID 18845990, PMID 19491285, PMID 19525947, PMID 19643599, PMID 19770418, PMID 19901100, PMID 20042969, PMID 20375404, PMID 20975604, PMID 21073974, PMID 21752720, PMID 21774104, PMID 21892283, PMID 24246506, PMID 25111859, PMID 25824692, PMID 25845992, PMID 26695839, PMID 27095655, PMID 27784746, PMID 27890801, PMID 28596308, PMID 28765502, PMID 30785198, PMID 30858085, PMID 32372672, PMID 32539805, PMID 32827353, PMID 33688020, PMID 34653525, PMID 34780125, PMID 36636059, PMID 36822667, PMID 37023987, PMID 37166053, PMID 37777738, PMID 39473059, PMID 39863139, PMID 40255171, PMID 40580957, PMID 40812353
U10CA032102 (7), P30CA015704 (3), P30CA033572 (3), P30CA043703 (3), U10CA021115 (3), P30CA006973 (2), U10CA021661 (2), 2005 (1), 2008 (1), 2009 (1), 2016 (1), 2019 (1), 2023 (1), K12CA076917 (1), K24CA139052 (1)